Additional disclosures to be made under SEBI’s revised Corporate Governance Report
The recommendations made by the Committee on Corporate Governance under the Chairmanship of Uday Kotak were incorporated by SEBI as...
Kneeling to ‘Royalty’?
SEBI’s decision to delay the implementation of shareholder approval for royalty payments is yet another tug-of-war between the market...
FY 20 : Expect a single-point board agenda
As companies enter the new financial year, there are a few lessons that the just completed year has had to offer. This year governance...
Sun Pharma: What investors should ask of its board
The whistle-blower allegations have raised governance concerns at Sun Pharma. Given its current structure, and the new SEBI-accepted...